Elon Musk bungles his criticism of U.S. drug regulators

admin
1 Min Read

Elon Musk criticized the U.S. government for issuing too many rules and regulations while campaigning for Donald Trump in Pennsylvania. He specifically mentioned the FDA and a cancer drug called Welireg, sharing a personal story of a friend’s mother being cured of brain cancer with the drug in a clinical trial. This story was originally featured in Adam’s Biotech Scorecard, a newsletter exclusively for subscribers. Readers can sign up to receive it in their inbox. Musk’s comments shed light on his views on government regulation and highlighted the potential benefits of innovative biotech treatments like Welireg.

Source link

Share This Article
error: Content is protected !!